XHEvsXPHETF Comparison
VS
State Street SPDR S&P Health Care Equipment ETF (XHE) and State Street SPDR S&P Pharmaceuticals ETF (XPH) belong to the same industry segment: US Health Care. XHE's top 2 sector exposures are Healthcare and Finance. In contrast, XPH's top sector exposures are Healthcare. Both XHE and XPH have the same Total Expense Ratio (TER) of 0.35%. XHE is up 4.24% year-to-date (YTD) with -$11M in YTD flows. XPH performs better with 14.7% YTD performance, and +$189M in YTD flows. Run a side-by-side ETF comparison of XHE and XPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
XHE vs XPH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/20/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XHE XPH | +0.58%-5.08% | +5.60%-4.11% | +4.24%+14.70% | +13.29%+31.28% | +30.79%+80.64% | -26.79%+41.72% |
| Flows | XHE XPH | -$43M-$97M | -$13M+$17M | -$11M+$189M | -$9M+$207M | -$227M+$163M | -$401M+$160M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XHE XPH | +20.73%+22.91% | +22.61%+23.19% | +21.97%+20.81% | +24.84%+21.07% |
| Max drawdown | XHE XPH | -9.09%-16.58% | -18.20%-16.58% | -24.35%-23.45% | -49.37%-30.87% |
| Max drawdown duration | XHE XPH | 62d62d | 207d62d | 565d322d | 1812d1452d |
Trading data
XHE | XPH | |
Last sale 10/21/2026 at 1:30 PM | $91.44 | $63.98 |
| Previous close 10/20/2026 | $91.78 | $64.15 |
| Consolidated volume 10/20/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
XHE | XPH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/21/2026 at 1:30 PM
Live
Closed
XHE | XPH | |
|---|---|---|
| Last price | $91.44 | $63.98 |
| 1D performance | -0.37% | -0.27% |
| AuM | $149.27 M | $452.34 M |
| E/R | 0.35% | 0.35% |
Characteristics
XHE | XPH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | State Street Investment Management | State Street Investment Management |
| Benchmark | S&P Health Care Equipment Select Industry Index | S&P Pharmaceuticals Select Industry Index |
| N° of holdings | 67 | 62 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 26, 2011 | June 19, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
XHE
USA
93.57%
Other
6.43%
XPH
USA
89.77%
Other
10.23%
Sectors
XHE
Healthcare
97.47%
Other
2.53%
XPH
Healthcare
93.27%
Other
6.73%
Advertisement
Diversification
XHE
Total weight of top 15 holdings out of 15
30.96%
XPH
Total weight of top 15 holdings out of 15
34.13%
Top 15 holdings
Data as of August 31, 2026
XHE
AtriCure, Inc.
2.59%
Strive, Inc. (United States)
2.47%
Inspire Medical Systems, Inc.
2.19%
Glaukos Corp.
2.16%
Butterfly Network, Inc.
2.15%
CONMED Corp.
2.02%
Integer Holdings Corp.
2.02%
Tandem Diabetes Care, Inc.
2.00%
Merit Medical Systems, Inc.
1.99%
Artivion, Inc.
1.94%
Haemonetics Corp.
1.93%
UFP Technologies, Inc.
1.89%
Baxter International, Inc.
1.88%
Becton, Dickinson & Co.
1.87%
Neogen Corp.
1.86%
XPH
Amylyx Pharmaceuticals, Inc.
3.65%
Crinetics Pharmaceuticals, Inc.
3.60%
MBX Biosciences, Inc.
2.89%
Omeros Corp.
2.68%
Enliven Therapeutics, Inc.
2.28%
Nuvation Bio, Inc.
2.12%
Corcept Therapeutics, Inc.
2.11%
Eton Pharmaceuticals, Inc.
2.08%
Perrigo Co. Plc
1.91%
Edgewise Therapeutics, Inc.
1.85%
Nektar Therapeutics
1.83%
Merck & Co., Inc.
1.81%
Trevi Therapeutics, Inc.
1.80%
Tarsus Pharmaceuticals, Inc.
1.76%
Bristol Myers Squibb Co.
1.75%
Frequently asked questions about XHE and XPH
How have the XHE and XPH ETFs performed in 2026?
As of October 20, 2026, XHE is up 4.24% year-to-date (YTD), while XPH has returned 14.7%. That puts XPH better performer ahead so far this year.
Which ETF is attracting more investor money: XHE or XPH?
Year-to-date, the XHE ETF saw -$11M in flows, compared to +$189M for XPH.
Which ETF is more volatile: XHE or XPH?
Over the past year, XHE had a volatility of 22.61%, while XPH experienced 23.19%.
Which ETF is bigger: XHE or XPH?
As of October 20, 2026, XHE holds $149.27 M in assets under management (AUM), while XPH manages $452.34 M.
What sectors do the XHE and XPH ETFs invest in?
XHE leans toward sectors like Healthcare. Meanwhile, XPH focuses on Healthcare.
What are the top holdings of the XHE ETF and XPH ETF?
XHE top holdings include AtriCure, Inc., Strive, Inc. (United States) and Inspire Medical Systems, Inc.. XPH holds in its top three: Amylyx Pharmaceuticals, Inc., Crinetics Pharmaceuticals, Inc. and MBX Biosciences, Inc..
Which ETF is more diversified: XHE or XPH?
XHE holds 67 securities with 30.96% of its assets in the top 15. XPH has 62 securities and a top 15 weight of 34.13%.
Advertisement
Latest news about XHE & XPH
Donald Trump’s Executive Orders: ETF Bulls and Bears
January 24, 2025
XPH
Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze
November 20, 2023
XPH
Advertisement
Advertisement
